SELLAS Life Sciences (SLS) Short term Debt (2013 - 2018)

SELLAS Life Sciences (SLS) has 6 years of Short term Debt data on file, last reported at $76000.0 in Q3 2018.

• Quarterly Short term Debt fell 99.38% year-over-year to $76000.0 in Q3 2018, while the trailing twelve-month figure through Sep 2018 was $76000.0 (down 99.38% YoY) and the FY2017 annual result came in at $8.4 million, up 390.17% from the prior year.
• Short term Debt slipped to $76000.0 in Q3 2018 per SLS's latest filing, from $7.8 million in the prior quarter.
• Across five years, Short term Debt topped out at $23.7 million in Q3 2016 and bottomed at $76000.0 in Q3 2018.
• The 5-year median for Short term Debt is $4.2 million (2015), against an average of $7.7 million.
• The widest annual swing landed in 2014, when Short term Debt surged 1254.15%; it then sank 99.38% in 2018.
• Tracing SLS's Short term Debt over 5 years: stood at $3.9 million in 2014, then advanced by 21.2% to $4.7 million in 2015, then sank by 63.94% to $1.7 million in 2016, then surged by 390.17% to $8.4 million in 2017, then plunged by 99.09% to $76000.0 in 2018.
• Per Business Quant, the three latest SLS Short term Debt figures stand at $76000.0 (Q3 2018), $7.8 million (Q2 2018), and $8.5 million (Q1 2018).

Peer Comparison